Table Of Contents
1. Introduction 18
1.1. Objectives Of The Study 18
1.2. Market Definition 18
1.3. Overview Of Asia-Pacific Microfluidics Market 18
1.4. Currency And Pricing 19
1.5. Limitation 19
1.6. Markets Covered 20
2. Market Segmentation 22
2.1. Markets Covered 22
2.2. Geographic Scope 23
2.3. Years Considered For The Study 24
2.4. Currency And Pricing 24
2.5. Research Methodology 25
2.6. Primary Interviews With Key Opinion Leaders 28
2.7. Secondary Sources 29
2.8. Assumptions 29
3. Market Overview 30
3.1. Drivers 32
3.1.1. Increased Demand Of Poc Testing 32
3.1.2. Wide Range Of Applications In Different Sectors 33
3.1.3. Benefits Associated With Incorporation Of Microfluidics 34
3.1.4. High Return On Investments 35
3.2. Restraints 37
3.2.1. Complexity In Incorporating Microfluidics Technology In The Existing Procedures 37
3.3. Opportunities 38
3.3.1. Lucrative Opportunities In Emerging Region 38
3.3.2. Rise In The Drug Discovery Research 40
3.4. Challenges 40
3.4.1. Lack Of Visibility In The Market 40
4. Executive Summary 41
5. Premium Insights 43
6. Asia-Pacific Microfluidics Market, By Component 46
6.1. Overview 47
6.2. Microfluidics Chips 48
6.3. Micropumps 50
6.4. Microneedles 52
6.5. Others 54
7. Asia-Pacific Microfluidics Market, By Material 56
7.1. Overview 57
7.2. Polymer 58
7.3. Glass 60
7.4. Silicon 61
7.5. Others 62
8. Asia-Pacific Microfluidics Market, By Sector 63
8.1. Overview 64
8.2. Healthcare 66
8.2.1. Poc Diagnostics 68
8.2.2. Cell Analysis 68
8.2.3. Drug Discovery 68
8.2.4. Immunoassays 69
8.2.5. Genotyping & Sequencing 69
8.2.6. Microarray Analysis 69
8.2.7. In-Vitro Diagnostics 70
8.2.8. Biomarker Analysis 70
8.2.9. Others 70
8.3. Industrial 71
8.3.1. Biotechnology 72
8.3.2. Energy 73
8.3.3. Nutraceuticals & Food 73
8.3.4. Cosmetics 73
8.3.5. Chemical 74
9. Asia-Pacific Microfluidics Market, By End User 75
9.1. Overview 76
9.2. Hospitals 78
9.3. Research Laboratories & Academia 79
9.4. Industrial R&D 80
10. Asia-Pacific Microfluidics Market, By Geography 81
10.1. Asia Pacific 81
10.1.1. Japan 92
10.1.2. China 96
10.1.3. India 100
10.1.4. South Korea 104
10.1.5. Australia 108
10.1.6. Singapore 112
10.1.7. Thailand 116
10.1.8. Malaysia 120
10.1.9. Indonesia 124
10.1.10. Philippines 129
10.1.11. Rest Of Asia Pacific 133
11. Asia-Pacific Microfluidics Market, Company Landscape 134
11.1. Company Share Analysis; Asia Pacific 134
12. Company Profiles 135
12.1. Perkinelmer Inc. 135
12.1.1. Company Overview 135
12.1.2. Perkinelmer Inc.; Revenue Analysis 136
12.1.3. Product Portfolio 137
12.1.4. Recent Developments 139
12.2. Dolomite Microfluidics 140
12.2.1. Company Overview 140
12.2.2. Dolomite Microfluidics; Company Snapshot 140
12.2.3. Product Portfolio 141
12.2.4. Recent Developments 143
12.3. Microfluidics 145
12.3.1. Company Overview 145
12.3.2. Microfluidics; Company Snapshot 145
12.3.3. Product Portfolio 146
12.3.4. Recent Developments 147
12.4. Abaxis 148
12.4.1. Company Overview 148
12.4.2. Abaxis; Revenue Analysis 148
12.4.3. Product Portfolio 149
12.4.4. Recent Developments 149
12.5. Abbott 150
12.5.1. Company Overview 150
12.5.2. Abbott; Revenue Analysis 150
12.5.3. Product Portfolio 151
12.5.4. Recent Developments 151
12.6. Agilent Technologies 152
12.6.1. Company Overview 152
12.6.2. Agilent Technologies;Revenue Analysis 152
12.6.3. Product Portfolio 153
12.6.4. Recent Developments 153
12.7. Akonni Biosystems Inc. 154
12.7.1. Company Overview 154
12.7.2. Akonni Biosystems, Inc.; Company Snapshot 154
12.7.3. Product Portfolio 155
12.7.4. Recent Developments 155
12.8. Aviva Biosciences 156
12.8.1. Company Overview 156
12.8.2. Aviva Biosciences; Company Snapshot 156
12.8.3. Product Portfolio 156
12.8.4. Recent Developments 156
12.9. Bio-Rad Laboratories Inc. 157
12.9.1. Company Overview 157
12.9.2. Bio-Rad Laboratories, Inc.; Revenue Analysis 157
12.9.3. Product Portfolio 158
12.9.4. Recent Developments 158
12.10. Cepheid 159
12.10.1. Company Overview 159
12.10.2. Cepheid; Company Snapshot 159
12.10.3. Product Portfolio 159
12.10.4. Recent Developments 159
12.11. Fluxion Bioscience 160
12.11.1. Company Overview 160
12.11.2. Fluxion Bioscience; Company Snapshot 160
12.11.3. Product Portfolio 161
12.11.4. Recent Developments 161
12.12. Hewlett-Packard 162
12.12.1. Company Overview 162
12.12.2. Hp Inc.; Revenue Analysis 162
12.12.3. Product Portfolio 163
12.12.4. Recent Developments 163
12.13. Illumina Inc. 164
12.13.1. Company Overview 164
12.13.2. Illumina, Inc.;Revenue Analysis 164
12.13.3. Product Portfolio 165
12.13.4. Recent Developments 165
12.14. Raindance Technologies Inc. 166
12.14.1. Company Overview 166
12.14.2. Raindance Technologies, Inc.; Company Snapshot 166
12.14.3. Product Portfolio 167
12.14.4. Recent Developments 167
12.15. Thermo Fisher Scientific Inc. 168
12.15.1. Company Overview 168
12.15.2. Thermo Fisher Scientific Inc. ;Revenue Analysis 168
12.15.3. Product Portfolio 169
12.15.4. Recent Developments 169
13. Related Reports 170